Ignite Creation Date:
2024-05-06 @ 3:47 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04753424
Status:
RECRUITING
Last Update Posted:
2022-06-23
First Post:
2021-01-06
Brief Title:
Semitendinosus Graft as Meniscal Transplant
Sponsor:
Karolinska Institutet
Organization:
Karolinska Institutet
Study Overview
Official Title:
Autologous Semitendinosus Tendon Graft as Meniscal Transplant - a Clinical Pilot Study
Status:
RECRUITING
Status Verified Date:
2022-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Removal of meniscal tissue is described to result in poor knee function and a significant risk for future development of osteoarthritis Different implants have been suggested to substitute a removed meniscus Meniscal allograft transplantation is not widely available due to costs and availability The semitendinosus tendon is a known graft with biological properties with potential to remodel and revascularize in an intraarticular environment such as anterior cruciate ligament reconstruction The objective for this study was to investigate whether the semitendinosus tendon graft could function as a meniscal transplant
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None